PP4 loss and airway epithelial senescence in severe asthma: abstract findings
In this abstract, PP4 was downregulated in airway epithelial cells from severe asthma patients; PP4 loss activated a PERK-eIF2α-ATF4-p21 axis and p21-dependent senescence, and a PERK inhibitor reduced senescence and IgE, IL-5 and IL-13 in a mouse model. [1]
Automatic summary · not editorially reviewed
The key findings
PP4 is reported as significantly downregulated in airway epithelial cells from patients with severe asthma. [1]
PP4 loss activated the PERK-eIF2α-ATF4-p21 axis and triggered p21-dependent senescence, mitochondrial dysfunction and calcium influx. [1]
In a house dust mite-induced mouse asthma model, the PERK inhibitor GSK2656157 attenuated airway epithelial senescence and reduced systemic IgE, IL-5 and IL-13. [1]
The source at a glance
- Study type / format
- Abstract of a mechanistic laboratory study with cell experiments, a mouse model and ex vivo human cell validation
- Population / context
- Airway epithelial cells from patients with severe asthma, PP4-deficient airway epithelial cells, a house dust mite-induced mouse asthma model and ex vivo human bronchial epithelial cells from severe asthmatic donors.
- Summary based on
- Study abstract
- Original publication
- September 27, 2026
PP4 downregulation in severe asthma epithelium
The abstract reports that protein phosphatase 4 (PP4), an enzyme with broad physiological functions, is significantly downregulated in airway epithelial cells derived from patients with severe asthma. The authors present this as a possible regulatory role in disease progression. The abstract does not report how many patients were studied or how the comparison group was defined.
Supporting source [1]
PERK axis and senescence in cell and mouse work
RNA sequencing of PP4-deficient airway epithelial cells showed upregulated endoplasmic reticulum stress genes. PP4 loss enhanced PERK phosphorylation and activated the PERK-eIF2α-ATF4-p21 axis, which triggered p21-dependent senescence, mitochondrial dysfunction and intracellular calcium influx. In a house dust mite-induced mouse asthma model, the PERK inhibitor GSK2656157 attenuated airway epithelial senescence and significantly reduced systemic IgE, IL-5 and IL-13. In air-liquid interface cultures of human bronchial epithelial cells from severe asthmatic donors, GSK2656157 suppressed p21-mediated senescence and the senescence-associated secretory phenotype.
Supporting source [1]
Abstract-only scope of the mechanistic claims
The abstract describes cell experiments, a mouse asthma model and ex vivo cultures of human bronchial epithelial cells. It does not report sample sizes, follow-up, effect sizes or statistical uncertainty. The findings concern airway epithelial senescence and inflammation markers in these systems, not human lifespan or aging outcomes. The proposed targeting of PP4-related pathways is described as a promising strategy, not as a validated treatment. The full text was not reviewed.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Sample sizes, follow-up, effect sizes and statistical uncertainty are not reported. Results come from cell experiments, a mouse asthma model and ex vivo human bronchial epithelial cultures, so they do not establish human lifespan or aging benefits.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Huang YT, Chen CY, Weng CM, Wang SA, Hsu SC, Yang FM. · europepmc.org · September 27, 2026